Atlantic Coastal Acquisition Corp. II (ACAB) Short Interest Ratio & Short Volume

Short interest is the volume of Atlantic Coastal Acquisition Corp. II shares that have been sold short but have not yet been closed out or covered. As of October 31st, investors have sold 3,500 shares of ACAB short. 0.49% of Atlantic Coastal Acquisition Corp. II's shares are currently sold short. Learn More on Atlantic Coastal Acquisition Corp. II's current short interest.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.49% of Atlantic Coastal Acquisition Corp. II's floating shares are currently sold short.

Atlantic Coastal Acquisition Corp. II saw a increase in short interest in the month of October. As of October 31st, there was short interest totaling 3,500 shares, an increase of 3,400.0% from the previous total of 100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Atlantic Coastal Acquisition Corp. II currently has issued a total of 8,170,000 shares. Some of Atlantic Coastal Acquisition Corp. II's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Atlantic Coastal Acquisition Corp. II currently has a public float of 717,400 shares.

0.49% of Atlantic Coastal Acquisition Corp. II's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Atlantic Coastal Acquisition Corp. II: Compass Therapeutics, Inc. (2.09%), Heron Therapeutics, Inc. (18.94%), Inozyme Pharma, Inc. (7.40%), Kyverna Therapeutics, Inc. (13.71%), Caribou Biosciences, Inc. (12.43%), Nkarta, Inc. (13.56%), Tenaya Therapeutics, Inc. (7.99%), Galectin Therapeutics Inc. (12.76%), DiaMedica Therapeutics Inc. (0.41%), MediWound Ltd. (8.20%),

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks.

Short selling ACAB is an investing strategy that aims to generate trading profit from Atlantic Coastal Acquisition Corp. II as its price is falling. ACAB shares are trading down $5.13 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Atlantic Coastal Acquisition Corp. II occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ACAB, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ACAB, twice per month. The most recent reporting period available is October, 31 2024.